CNIO - Spanish National Cancer Research Centre
Leonardo Garma is a skilled scientist with extensive research experience in bioinformatics, multi-omic analysis, and electrophysiology. Since April 2023, Leonardo has worked as a Staff Scientist at the CNIO - Spanish National Cancer Research Centre, focusing on the multi-omic analysis of metastatic cancer patients. Prior to this, a postdoctoral researcher at Karolinska Institutet from January 2020 to April 2023 involved bioinformatic analysis of single-cell sequencing data in the human and mouse striatum. Additional postdoctoral research at Istituto Italiano di Tecnologia emphasized the development and application of in vitro electrophysiology tools. Leonardo's educational background includes a PhD in Biochemistry from the University of Oulu and various master's degrees in Neuroscience and Biomedical Engineering, complemented by multiple advanced courses and summer schools across Europe.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.